POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE

POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE was reported 248 times

POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ACHLORHYDRIA 1 0.0143
1 SMALL CELL LUNG CANCER EXTENSIVE STAGE 1 0.0087
2 IMPLANT SITE VESICLES 1 0.0068
3 TOOTH DEVELOPMENT DISORDER 1 0.0068
4 SENSORY PROCESSING DISORDER 1 0.0059
5 METASTASES TO RETROPERITONEUM 1 0.0059
6 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 5 0.0047
7 PRODUCT INTOLERANCE 1 0.0045
8 SCLERAL DISORDER 1 0.0037
9 ENAMEL ANOMALY 1 0.0035
10 CREUTZFELDT-JAKOB DISEASE 1 0.0035
11 IMPLANT SITE EROSION 1 0.0034
12 BLOOD BILIRUBIN DECREASED 2 0.0032
13 VENOUS PRESSURE JUGULAR INCREASED 1 0.0028
14 DIET NONCOMPLIANCE 1 0.0027
15 CAPILLARY DISORDER 1 0.0026
16 ARACHNOID CYST 1 0.0025
17 BONE ABSCESS 1 0.0025
18 VIRAL RASH 1 0.0025
19 METASTASES TO THE MEDIASTINUM 1 0.0024
20 BONE INFARCTION 1 0.0022
21 ELECTROLYTE DEPLETION 1 0.0020
22 DYSPRAXIA 1 0.0018
23 LIFE EXPECTANCY SHORTENED 1 0.0018
24 MOTOR DEVELOPMENTAL DELAY 1 0.0017
25 CRYSTAL NEPHROPATHY 1 0.0017
26 INHALATION THERAPY 1 0.0016
27 NEPHROGENIC ANAEMIA 7 0.0015
28 DIET REFUSAL 1 0.0014
29 CENTRAL OBESITY 1 0.0014
30 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 1 0.0013
31 WOUND DRAINAGE 1 0.0013
32 HEMIANAESTHESIA 1 0.0013
33 HYPERPARATHYROIDISM SECONDARY 3 0.0012
34 HEPATIC CANCER METASTATIC 1 0.0012
35 TONGUE MOVEMENT DISTURBANCE 1 0.0012
36 ADENOCARCINOMA OF COLON 2 0.0011
37 STEREOTYPY 1 0.0011
38 PCO2 DECREASED 1 0.0010
39 TRAUMATIC LUNG INJURY 2 0.0010
40 HAEMOPHILUS INFECTION 1 0.0010
41 IMPLANT SITE ERYTHEMA 1 0.0010
42 HYDROCELE 1 0.0009
43 STREPTOCOCCAL BACTERAEMIA 1 0.0009
44 ARTERIAL HAEMORRHAGE 1 0.0009
45 CEREBRAL VENTRICLE DILATATION 1 0.0009
46 WEIGHT ABNORMAL 2 0.0008
47 RECTAL PROLAPSE 1 0.0008
48 PANCREATIC NEOPLASM 1 0.0008
49 IATROGENIC INJURY 1 0.0008
50 SLOW RESPONSE TO STIMULI 1 0.0008
51 VOMITING PROJECTILE 2 0.0007
52 GENERALISED ANXIETY DISORDER 1 0.0007
53 APRAXIA 1 0.0007
54 INTELLECTUAL DISABILITY 1 0.0007
55 INFECTIOUS PLEURAL EFFUSION 1 0.0007
56 PROCTALGIA 4 0.0006
57 GASTROINTESTINAL SOUNDS ABNORMAL 3 0.0006
58 MEAN CELL HAEMOGLOBIN INCREASED 1 0.0006
59 KYPHOSIS 1 0.0006
60 VOCAL CORD PARALYSIS 1 0.0006
61 RADIOTHERAPY 1 0.0005
62 OCCULT BLOOD POSITIVE 1 0.0005
63 PHYSICAL ASSAULT 1 0.0005
64 ENDOMETRIAL CANCER 1 0.0005
65 BLOOD LOSS ANAEMIA 1 0.0004
66 IMPLANT SITE INFECTION 1 0.0004
67 CONTRAST MEDIA REACTION 1 0.0004
68 ORAL INTAKE REDUCED 1 0.0004
69 MEAN CELL VOLUME INCREASED 1 0.0004
70 END STAGE RENAL DISEASE 7 0.0004
71 ANAL FISSURE 2 0.0004
72 BLOOD SODIUM INCREASED 1 0.0004
73 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 2 0.0004
74 ORAL FUNGAL INFECTION 1 0.0004
75 ACUTE LYMPHOCYTIC LEUKAEMIA 1 0.0004
76 TUMOUR HAEMORRHAGE 1 0.0004
77 PULMONARY PAIN 1 0.0003
78 REBOUND ACID HYPERSECRETION 1 0.0003
79 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
80 SELF INJURIOUS BEHAVIOUR 1 0.0003
81 BRAIN DEATH 1 0.0003
82 HEPATIC NEOPLASM 1 0.0003
83 PROSTATE CANCER METASTATIC 1 0.0003
84 EAR PRURITUS 1 0.0003
85 MUSCLE CONTRACTIONS INVOLUNTARY 1 0.0003
86 CONJUNCTIVAL HYPERAEMIA 1 0.0003
87 APPENDICECTOMY 1 0.0003
88 TONGUE OEDEMA 1 0.0003
89 SPINAL CORD COMPRESSION 1 0.0003
90 CEREBRAL ATROPHY 1 0.0003
91 OBSESSIVE-COMPULSIVE DISORDER 2 0.0002
92 INTERNATIONAL NORMALISED RATIO DECREASED 1 0.0002
93 HOMICIDAL IDEATION 1 0.0002
94 ABNORMAL FAECES 2 0.0002
95 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
96 BUNDLE BRANCH BLOCK LEFT 1 0.0002
97 ABNORMAL SENSATION IN EYE 1 0.0002
98 ANAL INCONTINENCE 2 0.0002
99 YELLOW SKIN 1 0.0002
100 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
101 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 1 0.0002
102 FLUID INTAKE REDUCED 1 0.0002
103 MALABSORPTION 1 0.0002
104 RENAL PAIN 2 0.0002
105 ANORECTAL DISCOMFORT 1 0.0002
106 INTESTINAL RESECTION 1 0.0002
107 BEHAVIOUR DISORDER 1 0.0002
108 ASPIRATION 2 0.0002
109 AUTISM SPECTRUM DISORDER 1 0.0002
110 CHOKING SENSATION 1 0.0002
111 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
112 MALNUTRITION 2 0.0002
113 PULMONARY ALVEOLAR HAEMORRHAGE 1 0.0002
114 FISTULA 2 0.0002
115 PERIORBITAL SWELLING 1 0.0002
116 SOCIAL AVOIDANT BEHAVIOUR 1 0.0002
117 STRESS CARDIOMYOPATHY 1 0.0002
118 CHRONIC KIDNEY DISEASE 13 0.0002
119 URINE ODOUR ABNORMAL 1 0.0002
120 PRE-EXISTING CONDITION IMPROVED 1 0.0002
121 INFUSION SITE SWELLING 1 0.0002
122 BRAIN OEDEMA 2 0.0002
123 C-REACTIVE PROTEIN ABNORMAL 1 0.0002
124 INCOHERENT 1 0.0002
125 RASH GENERALISED 4 0.0002
126 PRODUCT PREPARATION ISSUE 1 0.0002
127 ASPERGILLUS INFECTION 1 0.0002
128 IMMUNE SYSTEM DISORDER 2 0.0002
129 METASTASES TO LYMPH NODES 1 0.0001
130 DROOLING 1 0.0001
131 EXTRASYSTOLES 1 0.0001
132 PAPULE 1 0.0001
133 DIVERTICULUM 1 0.0001
134 ARTHROPOD BITE 1 0.0001
135 ACIDOSIS 1 0.0001
136 LIPASE INCREASED 1 0.0001
137 PROCEDURAL COMPLICATION 1 0.0001
138 RENAL FAILURE CHRONIC 1 0.0001
139 DIFFUSE LARGE B-CELL LYMPHOMA 1 0.0001
140 PELVIC FRACTURE 1 0.0001
141 PULMONARY HAEMORRHAGE 1 0.0001
142 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
143 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
144 AFFECTIVE DISORDER 1 0.0001
145 FURUNCLE 1 0.0001
146 RENAL CYST 1 0.0001
147 ABSCESS 2 0.0001
148 STENT PLACEMENT 1 0.0001
149 ASPHYXIA 1 0.0001
150 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
151 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
152 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
153 EMBOLISM 1 0.0001
154 HEMIPLEGIA 1 0.0001
155 PSYCHOLOGICAL TRAUMA 1 0.0001
156 ABDOMINAL DISTENSION 12 0.0001
157 EOSINOPHILIA 2 0.0001
158 APPENDICITIS 1 0.0001
159 BLOOD SODIUM DECREASED 2 0.0001
160 SPINAL DISORDER 1 0.0001
161 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
162 SINUS BRADYCARDIA 1 0.0001
163 RENAL TUBULAR NECROSIS 1 0.0001
164 HOSPICE CARE 1 0.0001
165 RENAL INJURY 3 0.0001
166 HAEMATOCRIT DECREASED 2 0.0001
167 HYPOTONIA 1 0.0001
168 OVARIAN CYST 1 0.0001
169 SALIVARY HYPERSECRETION 1 0.0001
170 AGGRESSION 5 0.0001
171 WEIGHT FLUCTUATION 1 0.0001
172 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
173 FULL BLOOD COUNT ABNORMAL 1 0.0001
174 EATING DISORDER 2 0.0001
175 BODY HEIGHT DECREASED 1 0.0001
176 GASTROINTESTINAL PAIN 1 0.0001
177 RENAL FAILURE 12 0.0001
178 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
179 FOOT DEFORMITY 1 0.0001
180 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
181 ORAL PAIN 2 0.0001
182 INTESTINAL PERFORATION 1 0.0001
183 FIBROMYALGIA 2 0.0001
184 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
185 SMALL INTESTINAL OBSTRUCTION 1 0.0001
186 APPLICATION SITE IRRITATION 1 0.0001
187 ABDOMINAL PAIN LOWER 2 0.0001
188 HAEMATEMESIS 2 0.0001
189 THERAPY CESSATION 4 0.0001
190 SKIN ULCER 2 0.0001
191 HIATUS HERNIA 1 0.0001
192 EYE HAEMORRHAGE 1 0.0001
193 PERIPHERAL COLDNESS 1 0.0001
194 RESPIRATORY DISTRESS 2 0.0001
195 VOMITING 34 0.0001
196 MENTAL STATUS CHANGES 2 0.0001
197 CARDIO-RESPIRATORY ARREST 3 0.0001
198 HAEMOPTYSIS 2 0.0001
199 PANCYTOPENIA 4 0.0001
200 BLOOD TEST ABNORMAL 1 0.0001
201 RED BLOOD CELL COUNT DECREASED 2 0.0001
202 HYPERTHYROIDISM 1 0.0001
203 INJECTION SITE HAEMATOMA 1 0.0001
204 LABORATORY TEST ABNORMAL 2 0.0001
205 SKIN HAEMORRHAGE 1 0.0001
206 COLON CANCER 1 0.0001
207 PULMONARY OEDEMA 3 0.0001
208 HAEMORRHAGE INTRACRANIAL 1 0.0001
209 ECONOMIC PROBLEM 1 0.0001
210 ACUTE KIDNEY INJURY 10 0.0001
211 EMOTIONAL DISORDER 2 0.0001
212 MUSCULOSKELETAL CHEST PAIN 1 0.0001
213 LUNG INFECTION 1 0.0001
214 ACUTE MYELOID LEUKAEMIA 1 0.0001
215 SWOLLEN TONGUE 2 0.0001
216 CYANOSIS 1 0.0001
217 HALLUCINATION, AUDITORY 1 0.0001
218 MOOD SWINGS 2 0.0001
219 GASTROOESOPHAGEAL REFLUX DISEASE 5 0.0001
220 MANIA 1 0.0001
221 STAPHYLOCOCCAL INFECTION 2 0.0001
222 URINARY RETENTION 2 0.0001
223 BLOOD UREA INCREASED 1 0.0001
224 CHILLS 7 0.0001
225 ANGER 2 0.0001
226 HAEMATURIA 2 0.0001
227 DELIRIUM 2 0.0001
228 PANCREATITIS 3 0.0001
229 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
230 LYMPHOCYTE COUNT DECREASED 1 0.0001
231 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
232 HEAD DISCOMFORT 1 0.0001
233 BACTERIAL INFECTION 1 0.0001
234 BLISTER 3 0.0001
235 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
236 DYSPNOEA EXERTIONAL 2 0.0001
237 INTESTINAL OBSTRUCTION 2 0.0001
238 FLATULENCE 3 0.0001
239 SLEEP APNOEA SYNDROME 1 0.0001
240 SEROTONIN SYNDROME 1 0.0001
241 ACUTE RESPIRATORY FAILURE 1 0.0001
242 HERNIA 1 0.0001
243 ERUCTATION 1 0.0001
244 CHOKING 1 0.0001
245 DISEASE PROGRESSION 6 0.0001
246 ABNORMAL BEHAVIOUR 2 0.0001
247 CONSTIPATION 11 0.0001
248 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 10 0.0000
249 NEUTROPHIL COUNT DECREASED 2 0.0000
250 TREMOR 8 0.0000
251 HALLUCINATION, VISUAL 1 0.0000
252 RENAL FAILURE ACUTE 2 0.0000
253 POOR QUALITY SLEEP 1 0.0000
254 SKIN CANCER 1 0.0000
255 FAECES DISCOLOURED 1 0.0000
256 SEPTIC SHOCK 2 0.0000
257 MENTAL DISORDER 2 0.0000
258 BLOOD PRESSURE DECREASED 3 0.0000
259 THROMBOCYTOPENIA 5 0.0000
260 CHROMATURIA 1 0.0000
261 NEPHROLITHIASIS 2 0.0000
262 SKIN DISCOLOURATION 2 0.0000
263 PERICARDIAL EFFUSION 1 0.0000
264 PNEUMONIA 14 0.0000
265 RENAL DISORDER 2 0.0000
266 COGNITIVE DISORDER 2 0.0000
267 ARRHYTHMIA 2 0.0000
268 DISEASE RECURRENCE 2 0.0000
269 DIABETIC KETOACIDOSIS 1 0.0000
270 PRESYNCOPE 1 0.0000
271 HYPOPHAGIA 1 0.0000
272 HEPATITIS 1 0.0000
273 HYPERHIDROSIS 5 0.0000
274 ABDOMINAL PAIN 9 0.0000
275 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
276 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
277 SPEECH DISORDER 2 0.0000
278 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
279 EAR INFECTION 1 0.0000
280 DEHYDRATION 5 0.0000
281 DRUG EFFECT DECREASED 2 0.0000
282 PALLOR 1 0.0000
283 PNEUMONITIS 1 0.0000
284 DIVERTICULITIS 1 0.0000
285 FEELING COLD 1 0.0000
286 INFLUENZA 4 0.0000
287 WOUND 1 0.0000
288 HYPONATRAEMIA 2 0.0000
289 TARDIVE DYSKINESIA 1 0.0000
290 NAUSEA 28 0.0000
291 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
292 ANGINA PECTORIS 1 0.0000
293 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
294 DYSSTASIA 1 0.0000
295 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
296 NASAL CONGESTION 2 0.0000
297 PSYCHOTIC DISORDER 1 0.0000
298 HEPATIC FAILURE 1 0.0000
299 APHASIA 1 0.0000
300 CORONARY ARTERY DISEASE 1 0.0000
301 THERAPEUTIC RESPONSE DECREASED 2 0.0000
302 DISCOMFORT 2 0.0000
303 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
304 CYSTITIS 1 0.0000
305 NIGHT SWEATS 1 0.0000
306 CHOLELITHIASIS 1 0.0000
307 DYSPEPSIA 3 0.0000
308 HEART RATE INCREASED 3 0.0000
309 INFUSION RELATED REACTION 2 0.0000
310 LIP SWELLING 1 0.0000
311 FUNGAL INFECTION 1 0.0000
312 EYE PRURITUS 1 0.0000
313 FLUSHING 3 0.0000
314 ASTHENIA 11 0.0000
315 HAEMOGLOBIN DECREASED 3 0.0000
316 ABDOMINAL PAIN UPPER 6 0.0000
317 MEMORY IMPAIRMENT 4 0.0000
318 NEOPLASM PROGRESSION 1 0.0000
319 BURNING SENSATION 2 0.0000
320 HYPERKALAEMIA 1 0.0000
321 LYMPHADENOPATHY 1 0.0000
322 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
323 MOBILITY DECREASED 2 0.0000
324 DRUG EFFECT INCOMPLETE 1 0.0000
325 RESPIRATORY FAILURE 2 0.0000
326 ACCIDENTAL OVERDOSE 1 0.0000
327 RESTLESSNESS 1 0.0000
328 AGITATION 2 0.0000
329 HYPOAESTHESIA 4 0.0000
330 HOT FLUSH 2 0.0000
331 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
332 PLASMA CELL MYELOMA 1 0.0000
333 DISORIENTATION 1 0.0000
334 CARDIAC FAILURE 2 0.0000
335 CARDIAC FAILURE CONGESTIVE 2 0.0000
336 DYSKINESIA 1 0.0000
337 OSTEOPOROSIS 1 0.0000
338 POLLAKIURIA 1 0.0000
339 SKIN EXFOLIATION 2 0.0000
340 OSTEOARTHRITIS 1 0.0000
341 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
342 GASTROINTESTINAL DISORDER 2 0.0000
343 THROAT IRRITATION 1 0.0000
344 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
345 CHEST PAIN 4 0.0000
346 HYPERSENSITIVITY 4 0.0000
347 PRODUCT USE ISSUE 4 0.0000
348 OCULAR HYPERAEMIA 1 0.0000
349 DYSPHAGIA 2 0.0000
350 PULMONARY EMBOLISM 2 0.0000
351 COMA 1 0.0000
352 PRODUCTIVE COUGH 1 0.0000
353 BLOOD GLUCOSE DECREASED 1 0.0000
354 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
355 HYPOGLYCAEMIA 1 0.0000
356 ATRIAL FIBRILLATION 2 0.0000
357 LUNG DISORDER 1 0.0000
358 ALOPECIA 4 0.0000
359 PYREXIA 7 0.0000
360 HYPOTENSION 4 0.0000
361 CELLULITIS 1 0.0000
362 FLUID RETENTION 1 0.0000
363 BLOOD PRESSURE INCREASED 3 0.0000
364 HOSPITALISATION 3 0.0000
365 DYSPNOEA 11 0.0000
366 ILLNESS 2 0.0000
367 INFLAMMATION 1 0.0000
368 HAEMORRHAGE 2 0.0000
369 PARAESTHESIA 3 0.0000
370 DEPRESSED MOOD 1 0.0000
371 CONFUSIONAL STATE 3 0.0000
372 DISTURBANCE IN ATTENTION 1 0.0000
373 ANAPHYLACTIC REACTION 1 0.0000
374 FATIGUE 14 0.0000
375 SEPSIS 2 0.0000
376 URTICARIA 3 0.0000
377 OXYGEN SATURATION DECREASED 1 0.0000
378 CEREBROVASCULAR ACCIDENT 3 0.0000
379 MYALGIA 3 0.0000
380 HEADACHE 11 0.0000
381 EYE IRRITATION 1 0.0000
382 SEIZURE 2 0.0000
383 DECREASED APPETITE 4 0.0000
384 DYSPHONIA 1 0.0000
385 DIARRHOEA 11 0.0000
386 WHEEZING 1 0.0000
387 IRRITABILITY 1 0.0000
388 PLEURAL EFFUSION 1 0.0000
389 FEELING HOT 1 0.0000
390 VISUAL IMPAIRMENT 2 0.0000
391 ANAEMIA 3 0.0000
392 RHINORRHOEA 1 0.0000
393 DEEP VEIN THROMBOSIS 1 0.0000
394 AMNESIA 1 0.0000
395 PRODUCT DOSE OMISSION 1 0.0000
396 BLOOD CREATININE INCREASED 1 0.0000
397 FEBRILE NEUTROPENIA 1 0.0000
398 FALL 5 0.0000
399 INSOMNIA 4 0.0000
400 NEOPLASM MALIGNANT 1 0.0000
401 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
402 INJECTION SITE REACTION 1 0.0000
403 COUGH 4 0.0000
404 INJURY 1 0.0000
405 SLEEP DISORDER 1 0.0000
406 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
407 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
408 THERAPY INTERRUPTED 1 0.0000
409 EPISTAXIS 1 0.0000
410 UNEVALUABLE EVENT 1 0.0000
411 DIABETES MELLITUS 1 0.0000
412 PRURITUS 5 0.0000
413 BACK PAIN 3 0.0000
414 ARTHRITIS 1 0.0000
415 DRUG INTERACTION 2 0.0000
416 FEELING ABNORMAL 3 0.0000
417 THROMBOSIS 1 0.0000
418 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
419 ABDOMINAL DISCOMFORT 2 0.0000
420 URINARY TRACT INFECTION 2 0.0000
421 DEATH 10 0.0000
422 BALANCE DISORDER 1 0.0000
423 MYOCARDIAL INFARCTION 2 0.0000
424 INTENTIONAL PRODUCT MISUSE 1 0.0000
425 MALAISE 5 0.0000
426 PAIN 7 0.0000
427 TACHYCARDIA 1 0.0000
428 ADVERSE DRUG REACTION 1 0.0000
429 ADVERSE EVENT 1 0.0000
430 OROPHARYNGEAL PAIN 1 0.0000
431 WEIGHT DECREASED 3 0.0000
432 DRUG INEFFECTIVE 14 0.0000
433 NEUROPATHY PERIPHERAL 1 0.0000
434 MIGRAINE 1 0.0000
435 GAIT DISTURBANCE 2 0.0000
436 CONTUSION 1 0.0000
437 PAIN IN EXTREMITY 3 0.0000
438 CONDITION AGGRAVATED 3 0.0000
439 SINUSITIS 1 0.0000
440 ERYTHEMA 2 0.0000
441 ARTHRALGIA 4 0.0000
442 HYPERTENSION 2 0.0000
443 PLATELET COUNT DECREASED 1 0.0000
444 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
445 WEIGHT INCREASED 2 0.0000
446 ASTHMA 1 0.0000
447 MUSCULAR WEAKNESS 1 0.0000
448 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
449 PALPITATIONS 1 0.0000
450 JOINT SWELLING 1 0.0000
451 OEDEMA PERIPHERAL 1 0.0000
452 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
453 DIZZINESS 4 0.0000
454 OFF LABEL USE 7 0.0000
455 DRY SKIN 1 0.0000
456 PRODUCT QUALITY ISSUE 1 0.0000
457 NEUTROPENIA 1 0.0000
458 TOXICITY TO VARIOUS AGENTS 1 0.0000
459 SOMNOLENCE 1 0.0000
460 OVERDOSE 1 0.0000
461 RASH 2 0.0000
462 ANXIETY 1 0.0000